News archive

The latest news stories from GMDN Agency.


  • Trustees Week
    Our Chair of Trustees, John Wilkinson shares how important volunteering is for him and for the cause as part of Trustees Week 2022.
    10 Nov 2022 · Case Study
  • The GMDN Agency welcomes new CEO, Deniz Bruce
    The board and team at GMDN are delighted to welcome Deniz Bruce as our new Chief Executive Officer. Read more about this next chapter for The GMDN Agency...
    09 Nov 2022
  • 20 years on from the first digital copy of GMDN
    In November, we are celebrating the 20 year anniversary of our first digital copy of the GMDN. The GMDN has grown incredibly in this time and is now used globally by more than 150 countries.
    04 Nov 2022 · Case Study
  • UDI Conference 9 November 2022
    The 12th annual UDI Conference 'UDI Beyond Borders, Harnessing Your Data for Medical Device Identification' is the industry gathering for medical device manufacturers, distributors, GPO’s and hospital systems to work through new and anticipated global UDI-related policies.
    28 Sep 2022 · Promotion
  • Colombia selects GMDN
    The National Institute of Surveillance of Medicines and Food (INVIMA) of Colombia has announced its new information system will use GMDN. We have been supporting Colombia in this implementation.
    23 Sep 2022
  • What is UDI?
    The Unique Device Identifier (UDI) is a number allocated to a product label. It is used to identify the manufacturer and other important product safety information. Read more about the benefits that UDI supports....
    22 Sep 2022
  • GMDN Update: Brazilian Portuguese Translations
    The GMDN has been updated to include Brazilian Portuguese translations. This will help to improve accuracy of assignment and drive forward the greater use of GMDN in Brazil.
    22 Sep 2022
  • TGA Consultation
    Detailed considerations for implementing the proposed Australian medical device UDI regulatory framework: A third UDI consultation paper from the TGA (Australian Therapeutic Good Administration)
    31 Aug 2022 · Promotion
  • UK Government to recommend use of GMDN following consultation
    Global harmonisation and patient safety was taken into consideration during the consultation. Read more about the report recommending the use of GMDN in the UK.
    27 Jun 2022
  • Retirement announcement: GMDN CEO, Mark Wasmuth
    After 12 years with the GMDN Agency, our CEO Mark Wasmuth has chosen to retire. The exact timing of Mark’s retirement is likely to be dependent upon the appointment of his successor.
    20 Jun 2022